Trademark Overview
On Monday, April 8, 2024, a trademark application was filed for SUMMIT THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the SUMMIT THERAPEUTICS trademark a serial number of 98489105. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, April 8, 2024. This trademark is owned by SUMMIT THERAPEUTICS SUB INC.. The SUMMIT THERAPEUTICS trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical preparations for use in the treatment of malignancies; pharmaceutical preparations, namely, antitumor agents; pharmaceutical preparations for use in humans for the treatment of cancer and immunological diseases; pharmaceutical preparations for the treatment of cancer and for use in oncology and immuno-oncology
Healthcare services, namely, providing patient treatment services in the fields of oncology and immuno-oncology; Provision of medical services in the field of oncology and immuno-oncology for the treatment of patients; Advice relating to oncology and immuno-oncology; Providing medical care services in the field of oncology and immuno-oncology; Providing information in the field of cancer; Medical counseling in the field of oncology and immuno-oncology; Medical consulting in the field of oncology and immuno-oncology
Drug discovery services for the identification and analysis of therapeutics for use in oncology and immuno-oncology; Research and development services in the field of therapeutics for the treatment of cancer; Research and development services in the fields of oncology and immuno-oncology; Providing medical and scientific research information in the field of biopharmaceuticals
